In a preceding paper of ours (Arakawa et al. 1973 b) it has been reported that some of epileptic children who had been receiving diphenylhydantoin showed a positive ferric chloride reaction of urine collected after an oral dose of L-histidineHCl, and that the positive ferric chloride reaction was due to imidazole pyruvic acid excreted in the urine. This finding led us to a speculation that there would be a defect in the hepatic histidase activity in some of children who had been treated with diphenylhydantoin.
Then our following animal experimentation revealed that a marked decrease in the hepatic histidase activity was brought about in rats given diphenylhydantoin for a period of 65 days (Arakawa et al. 1973 a) .
The present study was undertaken to observe a difference, if any, in serum histidine clearance after an intravenous injection of L-histidine-HC1 among children with or without diphenylhydantoin administration.
SUBJECTS AND METHODS
Ten patients, who aged from 10 to 29 years and were admitted in the Nishitaga National Hospital for mentally retarded, were divided into two groups (Groups A and B). Group A consisted of 5 epileptic children who were receiving diphenylhydantoin for a period from 6 to 13 years; Group B included five children without administration of dinhenylhvdantoin (cf. Table 1 ). Blood samples were taken in the morning after a night's last at 30, 60, 120 ana irsv min after an intravenous load of L-histidine-HCl (0.2 g/kg). The histidine solution used was prepared by dissolving L-histidine-HCl in saline at a concentration of 5%.
Serum histidine levels were measured using an automatic amino acid analyzer.
RESULTS AND DISCUSSION
Results shown in Table 2 nous injection of L-histidane-HCl in Group A (cf . Fig. 1) ; this tendency being also observed when (serum histidine levels at 60 minserum histidine levels at 180 min)=serum histidine levels at 60 minx 100% were calculated (cf . Table 3 and Fig. 2 ).
This result might be taken as an indirect evidence for the existence of a defec tive hepatic histidase activity of some of epileptic patients who were treated with diphenylhydantoin. 
